Balance Sheets (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current assets
Cash	$ 4,871	$ 6,642
Accounts receivable	2,428
Total current assets	7,299	6,642
Total assets	7,299	6,642
Current liabilities
Accounts payable and accrued liabilities	25,048	621
Notes payable	143,225
Due to related party	73,602	61,649
Total current liabilities	241,875	62,270
Total liabilities	241,875	62,270
Stockholders’ deficit
Preferred stock; $0.001 par value; 1,000,000 shares authorized, -0- issued and outstanding
Common stock; $0.0001 par value; 500,000,000 shares authorized, 208,000,000 and 118,000,0000 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively	20,800	11,800
Additional paid-incapital	5,523,200	5,335,200
Accumulated deficit during development stage	(5,695,653)	(5,402,628)
Total Innovative Product Opportunities, Inc. stockholders' deficit	(151,653)	(55,628)
Non-controlling interest	(82,923)
Total stockholders’ deficit	(234,576)	(55,628)
Total liabilities and stockholders’ deficit	$ 7,299	$ 6,642